|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
22
|
|
pubmed:dateCreated |
2011-7-29
|
|
pubmed:abstractText |
Results of allogeneic stem-cell transplantation (allo) in myeloma are controversial. In this trial autologous stem-cell transplantation (auto) followed by reduced-intensity conditioning matched sibling donor allo (auto-allo) was compared with auto only in previously untreated multiple myeloma.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:BeksacMeralM,
pubmed-author:BjörkstrandBoB,
pubmed-author:BosiAlbertoA,
pubmed-author:CorradiniPaoloP,
pubmed-author:GahrtonGöstaG,
pubmed-author:GoldschmidtHartmutH,
pubmed-author:GreinixHildegardH,
pubmed-author:GruberAstridA,
pubmed-author:HegenbartUteU,
pubmed-author:IacobelliSimonaS,
pubmed-author:MiloneGiuseppeG,
pubmed-author:MorrisCurlyC,
pubmed-author:MustoPellegrinoP,
pubmed-author:NarniFrancoF,
pubmed-author:NiederwieserDietgerD,
pubmed-author:VolinLiisaL,
pubmed-author:de WitteTheoT
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3016-22
|
|
pubmed:dateRevised |
2011-10-25
|
|
pubmed:meshHeading |
pubmed-meshheading:21730266-Adult,
pubmed-meshheading:21730266-Aged,
pubmed-meshheading:21730266-Disease-Free Survival,
pubmed-meshheading:21730266-Female,
pubmed-meshheading:21730266-Follow-Up Studies,
pubmed-meshheading:21730266-Graft vs Host Disease,
pubmed-meshheading:21730266-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:21730266-Humans,
pubmed-meshheading:21730266-Incidence,
pubmed-meshheading:21730266-Kaplan-Meier Estimate,
pubmed-meshheading:21730266-Male,
pubmed-meshheading:21730266-Middle Aged,
pubmed-meshheading:21730266-Multiple Myeloma,
pubmed-meshheading:21730266-Myeloablative Agonists,
pubmed-meshheading:21730266-Neoplasm Staging,
pubmed-meshheading:21730266-Prospective Studies,
pubmed-meshheading:21730266-Recurrence,
pubmed-meshheading:21730266-Time Factors,
pubmed-meshheading:21730266-Transplantation, Autologous,
pubmed-meshheading:21730266-Transplantation, Homologous,
pubmed-meshheading:21730266-Transplantation Conditioning,
pubmed-meshheading:21730266-Treatment Outcome,
pubmed-meshheading:21730266-Vidarabine
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up.
|
|
pubmed:affiliation |
Department of Medicine, Karolinska Institutet, Huddinge, SE-14186 Stockholm, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
